Hans Bishop
@hansbishop
Executive Officer, Director, Promoter
Building Juno Therapeutics, Inc. as Executive Officer, Director, Promoter
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Juno Therapeutics, Inc. was founded in 2013 and has no closure on record.
Named alongside
At GRAIL, Inc.
- Aaron FreidinExecutive Officer
- Brook T. ByersDirector
- CATHERINE FRIEDMANDirector
- Catherine T. FriedmanDirector
- Gregory SummeDirector
- HAL BARRONDirector
- Jeffrey HuberDirector
- Jeffrey T. HuberExecutive Officer, Director
- Anthony J. EvninDirector
- Bernard J. CassidyExecutive Officer
- Hal J. BarronDirector
- Howard J. PienDirector
- Hyam LevitskyExecutive Officer
- Jay J. FlatleyDirector
- Marc J. Tessier-LavigneDirector
- Mark FrohlichExecutive Officer, Promoter
- Catherine FriedmanDirector
- Elizabeth HomansExecutive Officer
- Heather TurnerExecutive Officer
- Margo RobertsExecutive Officer
- Nicholas RestifoExecutive Officer
- Richard GooldExecutive Officer
- Richard KlausnerExecutive Officer, Director, Promoter
- Robert NelsonDirector
Contribution
Hans's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Juno Therapeutics, Inc.Biological Products, (No Diagnostic Substances); filing with the SEC since 2013Executive Officer, Director, Promoter · Biotechnology · SEATTLE, United States · Founded 2013
- GRAIL, Inc.Services-Medical Laboratories; formerly GRAIL, LLC; listed on Nasdaq as GRAL; filing with the SEC since 2017Executive Officer, Director · Biotechnology · Menlo Park, United States
- Lyell Immunopharma, Inc.Pharmaceutical Preparations; listed on Nasdaq as LYEL; filing with the SEC since 2020Director · Pharmaceuticals · SOUTH SAN FRANCISCO, United States · Founded 2018